Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
ARD-501 by Aardvark Therapeutics for Autism Spectrum Disorder (ASD): Likelihood of Approval
ARD-501 is under clinical development by Aardvark Therapeutics and currently in Phase II for Autism Spectrum Disorder (ASD). According to...